Table 2.

Teaching points and perspectives for ACTH use in pediatric transplant patients

Recurrence of FSGS after renal transplantation is common and reduces allograft survival significantly

ACTH can be a safe and effective treatment option for therapy-resistant recurrent FSGS in pediatric transplant recipients

Future studies should investigate the potential of ACTH in children with FSGS recurrence and the safety of long-term use

ACTH, adrenocorticotropic hormone; FSGS, focal segmental glomerulosclerosis.